Advertisement
The Medicine Maker / Issues / 2026 / June / This Week's CGT News: World's First Solid Tumor CAR T Approved in China
Cell & Gene Industry News Research News

This Week's CGT News: World's First Solid Tumor CAR T Approved in China 

06/30/2026 5 min read News

Share

Advertisement

Recommended

Advertisement

Related Content

FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
Cell & Gene Industry News
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A

September 30, 2026

2 min read

Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated children with a natural history cohort

Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169
Cell & Gene Industry News Development & Clinical
Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169

September 28, 2026

3 min read

Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma

Novartis and BMS Pause Autoimmune CAR T Trials Over Safety Concerns
Cell & Gene Industry News
Novartis and BMS Pause Autoimmune CAR T Trials Over Safety Concerns

September 16, 2026

2 min read

Three deaths linked to immune effector cell-associated hemophagocytic syndrome prompt Novartis to halt eight rap-cel studies

Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer
Industry News Research News Cell & Gene
Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer

September 16, 2026

2 min read

All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group

Advertisement